Peptide Briefs

Epitalon (Epithalon, AEDG)

Evidence Grade: C — Telomerase findings rest on cell culture with one independent replication; animal data shows no mammalian lifespan effect; human data is on the bovine extract, not the synthetic peptide, and comes almost entirely from one Russian–Ukrainian research lineage.

What it is

Epitalon is the synthetic tetrapeptide Ala-Glu-Asp-Gly, developed at the St. Petersburg Institute of Bioregulation and Gerontology (Khavinson group) as a defined analogue of Epithalamin, a bovine pineal-gland extract studied in the Soviet Union from the late 1970s.

Proposed mechanism

Reported (not established) mechanisms include:

  • Activation of telomerase and telomere lengthening in cultured human cells
  • Restoration of melatonin secretion rhythm in aged animals
  • Regulation of gene expression via direct peptide–DNA interaction, a hypothesis the Khavinson group has advanced across many of its short peptides

What the literature shows

Cell: A 2003 study reported that Epitalon induced telomerase expression, enzymatic activity, and telomere elongation in telomerase-negative human fetal fibroblasts, extending the cultures’ division limit. A 2025 study from an independent group reported telomere lengthening in both normal cell lines and breast cancer cell lines — the first outside replication, and one that shows the effect is not limited to healthy cells.

Animal: The best-documented study (female SHR mice, 54 per group, lifelong monthly treatment) found no change in mean lifespan, body weight, or food intake. It did report slower age-related loss of estrous function and a 17% reduction in bone-marrow chromosome aberrations. Other reports from the same group describe reduced spontaneous tumor incidence in specific strains and lifespan extension in Drosophila. Mammalian lifespan claims are not supported by this study.

Human: The strongest human data is for Epithalamin (the extract), not Epitalon. A 12-year randomized study in elderly coronary patients (Ukraine) reported 28% lower all-cause mortality with Epithalamin added to standard care versus standard care alone; no placebo arm is described. A separate 266-person cohort followed for 6–8 years reported improved cardiovascular, endocrine, and immune indices. Published human data on the synthetic tetrapeptide itself is limited to small, uncontrolled reports.

Regulatory status

Not approved as a drug outside the former Soviet region. Not scheduled. Not on the WADA Prohibited List.

Gaps and caveats

  • Nearly all work is from a single research lineage; the 2025 cell-line study is the only independent replication, and animal and human findings remain unreplicated
  • Extract data (Epithalamin) is routinely cited as if it were data on the synthetic peptide — it is not
  • The one rigorous lifespan study in mice was negative on lifespan
  • Telomere lengthening in cancer cell lines is a finding that cuts both ways and is rarely mentioned in marketing
  • How a 4-amino-acid peptide reaches the nucleus intact and regulates transcription remains unexplained

Key references